The global HIV Diagnostic Test market was valued at US$ 4215 million in 2023 and is anticipated to reach US$ 7855 million by 2030, witnessing a CAGR of 9.2% during the forecast period 2024-2030.

HIV Diagnostic Test Market

HIV diagnosis tests are carried out to detect the presence of the virus.

The HIV diagnostic test market is driven by the increasing prevalence of HIV/AIDS and the growing focus on early detection and management of the disease. HIV diagnostic tests are essential tools used to identify the presence of the human immunodeficiency virus (HIV) in blood or saliva samples. The rise in the global burden of HIV/AIDS and the need for timely diagnosis to initiate antiretroviral therapy contribute to market growth. Moreover, advancements in testing technology, such as rapid and point-of-care tests, have improved the accessibility and efficiency of HIV diagnostics. However, the market also faces challenges, including the stigma associated with HIV testing and the need for increased awareness and access to testing in high-risk populations. Additionally, addressing the variability of HIV strains and ensuring the accuracy and sensitivity of diagnostic tests can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and reliable HIV diagnostic tests, collaborate with healthcare providers and public health agencies to expand testing initiatives, and address the challenges to meet the increasing demand for effective HIV detection and management solutions.

This report aims to provide a comprehensive presentation of the global market for HIV Diagnostic Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Diagnostic Test.

Report Scope

The HIV Diagnostic Test market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HIV Diagnostic Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HIV Diagnostic Test manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of HIV Diagnostic Test Market Report

Report Metric	Details
Report Name	HIV Diagnostic Test Market
Accounted market size in 2023	US$ 4215 million
Forecasted market size in 2030	US$ 7855 million
CAGR	9.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Antibody Test HIV-1 Test Other
Segment by Application	Hospitals Diagnostics Laboratories Blood Banks Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott Healthcare, BD Biosciences, Roche Diagnostics, Zyomyx Incorporation, Merck, Bristol –Myres Squibb, J &J, Hologic Incorporation, Chembio Diagnostic Systems, Sysmex, Gilead Sciences, Qiagen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HIV Diagnostic Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HIV Diagnostic Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is HIV Diagnostic Test Market growing?

Ans: The HIV Diagnostic Test Market witnessing a CAGR of 9.2% during the forecast period 2024-2030.

What is the HIV Diagnostic Test Market size in 2030?

Ans: The HIV Diagnostic Test Market size in 2030 will be US$ 7855 million.

Who are the main players in the HIV Diagnostic Test Market report?

Ans: The main players in the HIV Diagnostic Test Market are Abbott Healthcare, BD Biosciences, Roche Diagnostics, Zyomyx Incorporation, Merck, Bristol –Myres Squibb, J &J, Hologic Incorporation, Chembio Diagnostic Systems, Sysmex, Gilead Sciences, Qiagen

What are the Application segmentation covered in the HIV Diagnostic Test Market report?

Ans: The Applications covered in the HIV Diagnostic Test Market report are Hospitals, Diagnostics Laboratories, Blood Banks, Others

What are the Type segmentation covered in the HIV Diagnostic Test Market report?

Ans: The Types covered in the HIV Diagnostic Test Market report are Antibody Test, HIV-1 Test, Other

1 HIV Diagnostic Test Market Overview

1.1 Product Overview and Scope of HIV Diagnostic Test

1.2 HIV Diagnostic Test Segment by Type

1.2.1 Global HIV Diagnostic Test Market Value Comparison by Type (2024-2030)

1.2.2 Antibody Test

1.2.3 HIV-1 Test

1.2.4 Other

1.3 HIV Diagnostic Test Segment by Application

1.3.1 Global HIV Diagnostic Test Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Diagnostics Laboratories

1.3.4 Blood Banks

1.3.5 Others

1.4 Global HIV Diagnostic Test Market Size Estimates and Forecasts

1.4.1 Global HIV Diagnostic Test Revenue 2019-2030

1.4.2 Global HIV Diagnostic Test Sales 2019-2030

1.4.3 Global HIV Diagnostic Test Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 HIV Diagnostic Test Market Competition by Manufacturers

2.1 Global HIV Diagnostic Test Sales Market Share by Manufacturers (2019-2024)

2.2 Global HIV Diagnostic Test Revenue Market Share by Manufacturers (2019-2024)

2.3 Global HIV Diagnostic Test Average Price by Manufacturers (2019-2024)

2.4 Global HIV Diagnostic Test Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of HIV Diagnostic Test, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of HIV Diagnostic Test, Product Type & Application

2.7 HIV Diagnostic Test Market Competitive Situation and Trends

2.7.1 HIV Diagnostic Test Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest HIV Diagnostic Test Players Market Share by Revenue

2.7.3 Global HIV Diagnostic Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 HIV Diagnostic Test Retrospective Market Scenario by Region

3.1 Global HIV Diagnostic Test Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global HIV Diagnostic Test Global HIV Diagnostic Test Sales by Region: 2019-2030

3.2.1 Global HIV Diagnostic Test Sales by Region: 2019-2024

3.2.2 Global HIV Diagnostic Test Sales by Region: 2025-2030

3.3 Global HIV Diagnostic Test Global HIV Diagnostic Test Revenue by Region: 2019-2030

3.3.1 Global HIV Diagnostic Test Revenue by Region: 2019-2024

3.3.2 Global HIV Diagnostic Test Revenue by Region: 2025-2030

3.4 North America HIV Diagnostic Test Market Facts & Figures by Country

3.4.1 North America HIV Diagnostic Test Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America HIV Diagnostic Test Sales by Country (2019-2030)

3.4.3 North America HIV Diagnostic Test Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe HIV Diagnostic Test Market Facts & Figures by Country

3.5.1 Europe HIV Diagnostic Test Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe HIV Diagnostic Test Sales by Country (2019-2030)

3.5.3 Europe HIV Diagnostic Test Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific HIV Diagnostic Test Market Facts & Figures by Country

3.6.1 Asia Pacific HIV Diagnostic Test Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific HIV Diagnostic Test Sales by Country (2019-2030)

3.6.3 Asia Pacific HIV Diagnostic Test Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America HIV Diagnostic Test Market Facts & Figures by Country

3.7.1 Latin America HIV Diagnostic Test Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America HIV Diagnostic Test Sales by Country (2019-2030)

3.7.3 Latin America HIV Diagnostic Test Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa HIV Diagnostic Test Market Facts & Figures by Country

3.8.1 Middle East and Africa HIV Diagnostic Test Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa HIV Diagnostic Test Sales by Country (2019-2030)

3.8.3 Middle East and Africa HIV Diagnostic Test Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global HIV Diagnostic Test Sales by Type (2019-2030)

4.1.1 Global HIV Diagnostic Test Sales by Type (2019-2024)

4.1.2 Global HIV Diagnostic Test Sales by Type (2025-2030)

4.1.3 Global HIV Diagnostic Test Sales Market Share by Type (2019-2030)

4.2 Global HIV Diagnostic Test Revenue by Type (2019-2030)

4.2.1 Global HIV Diagnostic Test Revenue by Type (2019-2024)

4.2.2 Global HIV Diagnostic Test Revenue by Type (2025-2030)

4.2.3 Global HIV Diagnostic Test Revenue Market Share by Type (2019-2030)

4.3 Global HIV Diagnostic Test Price by Type (2019-2030)

5 Segment by Application

5.1 Global HIV Diagnostic Test Sales by Application (2019-2030)

5.1.1 Global HIV Diagnostic Test Sales by Application (2019-2024)

5.1.2 Global HIV Diagnostic Test Sales by Application (2025-2030)

5.1.3 Global HIV Diagnostic Test Sales Market Share by Application (2019-2030)

5.2 Global HIV Diagnostic Test Revenue by Application (2019-2030)

5.2.1 Global HIV Diagnostic Test Revenue by Application (2019-2024)

5.2.2 Global HIV Diagnostic Test Revenue by Application (2025-2030)

5.2.3 Global HIV Diagnostic Test Revenue Market Share by Application (2019-2030)

5.3 Global HIV Diagnostic Test Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Abbott Healthcare

6.1.1 Abbott Healthcare Corporation Information

6.1.2 Abbott Healthcare Description and Business Overview

6.1.3 Abbott Healthcare HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Abbott Healthcare HIV Diagnostic Test Product Portfolio

6.1.5 Abbott Healthcare Recent Developments/Updates

6.2 BD Biosciences

6.2.1 BD Biosciences Corporation Information

6.2.2 BD Biosciences Description and Business Overview

6.2.3 BD Biosciences HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.2.4 BD Biosciences HIV Diagnostic Test Product Portfolio

6.2.5 BD Biosciences Recent Developments/Updates

6.3 Roche Diagnostics

6.3.1 Roche Diagnostics Corporation Information

6.3.2 Roche Diagnostics Description and Business Overview

6.3.3 Roche Diagnostics HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Roche Diagnostics HIV Diagnostic Test Product Portfolio

6.3.5 Roche Diagnostics Recent Developments/Updates

6.4 Zyomyx Incorporation

6.4.1 Zyomyx Incorporation Corporation Information

6.4.2 Zyomyx Incorporation Description and Business Overview

6.4.3 Zyomyx Incorporation HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Zyomyx Incorporation HIV Diagnostic Test Product Portfolio

6.4.5 Zyomyx Incorporation Recent Developments/Updates

6.5 Merck

6.5.1 Merck Corporation Information

6.5.2 Merck Description and Business Overview

6.5.3 Merck HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Merck HIV Diagnostic Test Product Portfolio

6.5.5 Merck Recent Developments/Updates

6.6 Bristol –Myres Squibb

6.6.1 Bristol –Myres Squibb Corporation Information

6.6.2 Bristol –Myres Squibb Description and Business Overview

6.6.3 Bristol –Myres Squibb HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Bristol –Myres Squibb HIV Diagnostic Test Product Portfolio

6.6.5 Bristol –Myres Squibb Recent Developments/Updates

6.7 J &J

6.6.1 J &J Corporation Information

6.6.2 J &J Description and Business Overview

6.6.3 J &J HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.4.4 J &J HIV Diagnostic Test Product Portfolio

6.7.5 J &J Recent Developments/Updates

6.8 Hologic Incorporation

6.8.1 Hologic Incorporation Corporation Information

6.8.2 Hologic Incorporation Description and Business Overview

6.8.3 Hologic Incorporation HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Hologic Incorporation HIV Diagnostic Test Product Portfolio

6.8.5 Hologic Incorporation Recent Developments/Updates

6.9 Chembio Diagnostic Systems

6.9.1 Chembio Diagnostic Systems Corporation Information

6.9.2 Chembio Diagnostic Systems Description and Business Overview

6.9.3 Chembio Diagnostic Systems HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Chembio Diagnostic Systems HIV Diagnostic Test Product Portfolio

6.9.5 Chembio Diagnostic Systems Recent Developments/Updates

6.10 Sysmex

6.10.1 Sysmex Corporation Information

6.10.2 Sysmex Description and Business Overview

6.10.3 Sysmex HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Sysmex HIV Diagnostic Test Product Portfolio

6.10.5 Sysmex Recent Developments/Updates

6.11 Gilead Sciences

6.11.1 Gilead Sciences Corporation Information

6.11.2 Gilead Sciences HIV Diagnostic Test Description and Business Overview

6.11.3 Gilead Sciences HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Gilead Sciences HIV Diagnostic Test Product Portfolio

6.11.5 Gilead Sciences Recent Developments/Updates

6.12 Qiagen

6.12.1 Qiagen Corporation Information

6.12.2 Qiagen HIV Diagnostic Test Description and Business Overview

6.12.3 Qiagen HIV Diagnostic Test Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Qiagen HIV Diagnostic Test Product Portfolio

6.12.5 Qiagen Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 HIV Diagnostic Test Industry Chain Analysis

7.2 HIV Diagnostic Test Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 HIV Diagnostic Test Production Mode & Process

7.4 HIV Diagnostic Test Sales and Marketing

7.4.1 HIV Diagnostic Test Sales Channels

7.4.2 HIV Diagnostic Test Distributors

7.5 HIV Diagnostic Test Customers

8 HIV Diagnostic Test Market Dynamics

8.1 HIV Diagnostic Test Industry Trends

8.2 HIV Diagnostic Test Market Drivers

8.3 HIV Diagnostic Test Market Challenges

8.4 HIV Diagnostic Test Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bristol –Myres Squibb

J & J

Hologic Incorporation

Chembio Diagnostic Systems

Sysmex

Gilead Sciences

Qiagen NV

List of Tables

Table 1. Global HIV Diagnostic Test Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global HIV Diagnostic Test Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global HIV Diagnostic Test Market Competitive Situation by Manufacturers in 2023

Table 4. Global HIV Diagnostic Test Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global HIV Diagnostic Test Sales Market Share by Manufacturers (2019-2024)

Table 6. Global HIV Diagnostic Test Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global HIV Diagnostic Test Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market HIV Diagnostic Test Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of HIV Diagnostic Test, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of HIV Diagnostic Test, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of HIV Diagnostic Test, Product Type & Application

Table 12. Global Key Manufacturers of HIV Diagnostic Test, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global HIV Diagnostic Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostic Test as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global HIV Diagnostic Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global HIV Diagnostic Test Sales by Region (2019-2024) & (K Units)

Table 18. Global HIV Diagnostic Test Sales Market Share by Region (2019-2024)

Table 19. Global HIV Diagnostic Test Sales by Region (2025-2030) & (K Units)

Table 20. Global HIV Diagnostic Test Sales Market Share by Region (2025-2030)

Table 21. Global HIV Diagnostic Test Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global HIV Diagnostic Test Revenue Market Share by Region (2019-2024)

Table 23. Global HIV Diagnostic Test Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global HIV Diagnostic Test Revenue Market Share by Region (2025-2030)

Table 25. North America HIV Diagnostic Test Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America HIV Diagnostic Test Sales by Country (2019-2024) & (K Units)

Table 27. North America HIV Diagnostic Test Sales by Country (2025-2030) & (K Units)

Table 28. North America HIV Diagnostic Test Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America HIV Diagnostic Test Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe HIV Diagnostic Test Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe HIV Diagnostic Test Sales by Country (2019-2024) & (K Units)

Table 32. Europe HIV Diagnostic Test Sales by Country (2025-2030) & (K Units)

Table 33. Europe HIV Diagnostic Test Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe HIV Diagnostic Test Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific HIV Diagnostic Test Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific HIV Diagnostic Test Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific HIV Diagnostic Test Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific HIV Diagnostic Test Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific HIV Diagnostic Test Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America HIV Diagnostic Test Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America HIV Diagnostic Test Sales by Country (2019-2024) & (K Units)

Table 42. Latin America HIV Diagnostic Test Sales by Country (2025-2030) & (K Units)

Table 43. Latin America HIV Diagnostic Test Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America HIV Diagnostic Test Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa HIV Diagnostic Test Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa HIV Diagnostic Test Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa HIV Diagnostic Test Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa HIV Diagnostic Test Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa HIV Diagnostic Test Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global HIV Diagnostic Test Sales (K Units) by Type (2019-2024)

Table 51. Global HIV Diagnostic Test Sales (K Units) by Type (2025-2030)

Table 52. Global HIV Diagnostic Test Sales Market Share by Type (2019-2024)

Table 53. Global HIV Diagnostic Test Sales Market Share by Type (2025-2030)

Table 54. Global HIV Diagnostic Test Revenue (US$ Million) by Type (2019-2024)

Table 55. Global HIV Diagnostic Test Revenue (US$ Million) by Type (2025-2030)

Table 56. Global HIV Diagnostic Test Revenue Market Share by Type (2019-2024)

Table 57. Global HIV Diagnostic Test Revenue Market Share by Type (2025-2030)

Table 58. Global HIV Diagnostic Test Price (USD/Unit) by Type (2019-2024)

Table 59. Global HIV Diagnostic Test Price (USD/Unit) by Type (2025-2030)

Table 60. Global HIV Diagnostic Test Sales (K Units) by Application (2019-2024)

Table 61. Global HIV Diagnostic Test Sales (K Units) by Application (2025-2030)

Table 62. Global HIV Diagnostic Test Sales Market Share by Application (2019-2024)

Table 63. Global HIV Diagnostic Test Sales Market Share by Application (2025-2030)

Table 64. Global HIV Diagnostic Test Revenue (US$ Million) by Application (2019-2024)

Table 65. Global HIV Diagnostic Test Revenue (US$ Million) by Application (2025-2030)

Table 66. Global HIV Diagnostic Test Revenue Market Share by Application (2019-2024)

Table 67. Global HIV Diagnostic Test Revenue Market Share by Application (2025-2030)

Table 68. Global HIV Diagnostic Test Price (USD/Unit) by Application (2019-2024)

Table 69. Global HIV Diagnostic Test Price (USD/Unit) by Application (2025-2030)

Table 70. Abbott Healthcare Corporation Information

Table 71. Abbott Healthcare Description and Business Overview

Table 72. Abbott Healthcare HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Abbott Healthcare HIV Diagnostic Test Product

Table 74. Abbott Healthcare Recent Developments/Updates

Table 75. BD Biosciences Corporation Information

Table 76. BD Biosciences Description and Business Overview

Table 77. BD Biosciences HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. BD Biosciences HIV Diagnostic Test Product

Table 79. BD Biosciences Recent Developments/Updates

Table 80. Roche Diagnostics Corporation Information

Table 81. Roche Diagnostics Description and Business Overview

Table 82. Roche Diagnostics HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Roche Diagnostics HIV Diagnostic Test Product

Table 84. Roche Diagnostics Recent Developments/Updates

Table 85. Zyomyx Incorporation Corporation Information

Table 86. Zyomyx Incorporation Description and Business Overview

Table 87. Zyomyx Incorporation HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Zyomyx Incorporation HIV Diagnostic Test Product

Table 89. Zyomyx Incorporation Recent Developments/Updates

Table 90. Merck Corporation Information

Table 91. Merck Description and Business Overview

Table 92. Merck HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Merck HIV Diagnostic Test Product

Table 94. Merck Recent Developments/Updates

Table 95. Bristol –Myres Squibb Corporation Information

Table 96. Bristol –Myres Squibb Description and Business Overview

Table 97. Bristol –Myres Squibb HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Bristol –Myres Squibb HIV Diagnostic Test Product

Table 99. Bristol –Myres Squibb Recent Developments/Updates

Table 100. J &J Corporation Information

Table 101. J &J Description and Business Overview

Table 102. J &J HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. J &J HIV Diagnostic Test Product

Table 104. J &J Recent Developments/Updates

Table 105. Hologic Incorporation Corporation Information

Table 106. Hologic Incorporation Description and Business Overview

Table 107. Hologic Incorporation HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Hologic Incorporation HIV Diagnostic Test Product

Table 109. Hologic Incorporation Recent Developments/Updates

Table 110. Chembio Diagnostic Systems Corporation Information

Table 111. Chembio Diagnostic Systems Description and Business Overview

Table 112. Chembio Diagnostic Systems HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Chembio Diagnostic Systems HIV Diagnostic Test Product

Table 114. Chembio Diagnostic Systems Recent Developments/Updates

Table 115. Sysmex Corporation Information

Table 116. Sysmex Description and Business Overview

Table 117. Sysmex HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Sysmex HIV Diagnostic Test Product

Table 119. Sysmex Recent Developments/Updates

Table 120. Gilead Sciences Corporation Information

Table 121. Gilead Sciences Description and Business Overview

Table 122. Gilead Sciences HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Gilead Sciences HIV Diagnostic Test Product

Table 124. Gilead Sciences Recent Developments/Updates

Table 125. Qiagen Corporation Information

Table 126. Qiagen Description and Business Overview

Table 127. Qiagen HIV Diagnostic Test Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Qiagen HIV Diagnostic Test Product

Table 129. Qiagen Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. HIV Diagnostic Test Distributors List

Table 133. HIV Diagnostic Test Customers List

Table 134. HIV Diagnostic Test Market Trends

Table 135. HIV Diagnostic Test Market Drivers

Table 136. HIV Diagnostic Test Market Challenges

Table 137. HIV Diagnostic Test Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of HIV Diagnostic Test

Figure 2. Global HIV Diagnostic Test Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global HIV Diagnostic Test Market Share by Type in 2023 & 2030

Figure 4. Antibody Test Product Picture

Figure 5. HIV-1 Test Product Picture

Figure 6. Other Product Picture

Figure 7. Global HIV Diagnostic Test Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global HIV Diagnostic Test Market Share by Application in 2023 & 2030

Figure 9. Hospitals

Figure 10. Diagnostics Laboratories

Figure 11. Blood Banks

Figure 12. Others

Figure 13. Global HIV Diagnostic Test Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global HIV Diagnostic Test Market Size (2019-2030) & (US$ Million)

Figure 15. Global HIV Diagnostic Test Sales (2019-2030) & (K Units)

Figure 16. Global HIV Diagnostic Test Average Price (USD/Unit) & (2019-2030)

Figure 17. HIV Diagnostic Test Report Years Considered

Figure 18. HIV Diagnostic Test Sales Share by Manufacturers in 2023

Figure 19. Global HIV Diagnostic Test Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest HIV Diagnostic Test Players: Market Share by Revenue in 2023

Figure 21. HIV Diagnostic Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global HIV Diagnostic Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America HIV Diagnostic Test Sales Market Share by Country (2019-2030)

Figure 24. North America HIV Diagnostic Test Revenue Market Share by Country (2019-2030)

Figure 25. U.S. HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe HIV Diagnostic Test Sales Market Share by Country (2019-2030)

Figure 28. Europe HIV Diagnostic Test Revenue Market Share by Country (2019-2030)

Figure 29. Germany HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific HIV Diagnostic Test Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific HIV Diagnostic Test Revenue Market Share by Region (2019-2030)

Figure 36. China HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America HIV Diagnostic Test Sales Market Share by Country (2019-2030)

Figure 47. Latin America HIV Diagnostic Test Revenue Market Share by Country (2019-2030)

Figure 48. Mexico HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa HIV Diagnostic Test Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa HIV Diagnostic Test Revenue Market Share by Country (2019-2030)

Figure 53. Turkey HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. U.A.E HIV Diagnostic Test Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of HIV Diagnostic Test by Type (2019-2030)

Figure 57. Global Revenue Market Share of HIV Diagnostic Test by Type (2019-2030)

Figure 58. Global HIV Diagnostic Test Price (USD/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of HIV Diagnostic Test by Application (2019-2030)

Figure 60. Global Revenue Market Share of HIV Diagnostic Test by Application (2019-2030)

Figure 61. Global HIV Diagnostic Test Price (USD/Unit) by Application (2019-2030)

Figure 62. HIV Diagnostic Test Value Chain

Figure 63. HIV Diagnostic Test Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions